Expression of stem-cell markers (cytokeratin 15 and nestin) in primary adnexal neoplasms-clues to etiopathogenesis

American Journal of Dermatopathology

Volumn 32, Issue 8, 2010, Pages 774-779

  Mahalingam, Meera ^a   Srivastava, Anvita ^a   Hoang, Mai P ^b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

adnexal neoplasm; apocrine; cytokeratin 15; eccrine; nestin

Indexed keywords

CYTOKERATIN 15; NESTIN;

ADNEXA DISEASE; ARTICLE; BENIGN SKIN TUMOR; CLINICAL TRIAL; CYLINDROMA; CYSTADENOMA; FIBROADENOMA; HIDRADENOMA; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MIXED TUMOR; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL; SWEAT GLAND CARCINOMA; SWEAT GLAND TUMOR;

APOCRINE GLANDS; BOSTON; CELL LINEAGE; DIAGNOSIS, DIFFERENTIAL; ECCRINE GLANDS; HUMANS; IMMUNOHISTOCHEMISTRY; INTERMEDIATE FILAMENT PROTEINS; KERATIN-15; NEOPLASMS, ADNEXAL AND SKIN APPENDAGE; NEOPLASTIC STEM CELLS; NERVE TISSUE PROTEINS; PREDICTIVE VALUE OF TESTS; SWEAT GLAND NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 78650415639     PISSN: 01931091     EISSN: None     Source Type: Journal    
DOI: 10.1097/DAD.0b013e3181dafd8c     Document Type: Article

References (44)

1. McCalmont TH. A call for logic in the classification of adnexal neoplasms. Am J Dermatopathol. 1996;18:111-115.
2. Santa Cruz DJ. Sweat gland carcinomas: a comprehensive review. Semin Diagn Pathol. 1987;4:38.
3. Chamberlain R, Huber K, White J, et al. Apocrine gland carcinoma of the axilla: review of the literature and recommendations for treatment. Am J Clin Oncol. 1999;22:131-135.
4. Penneys NS, Nadji M, Morales A. Carcinoembryonic antigen in benign sweat gland tumors. Arch Dermatol. 1982;118:225-227.
5. Heyderman E, Graham RM, Chapman DV, et al. Epithelial markers in primary skin cancer: an immunoperoxidase study of the distribution of epithelial membrane antigen (EMA) and carcinoembryonic antigen (CEA) in 65 primary skin carcinomas. Histopathology. 1984;8:423-434.
6. Swanson PE, Cherwitz DL, Neumann MP, et al. Eccrine sweat gland carcinoma: a histologic and immunohistochemical study of 32 cases. J Cutan Pathol. 1987;14:65-86.
7. Mazoujian G, Margolis R. Immunohistochemistry of gross cystic disease fluid protein (GCDFP-15) in 65 benign sweat gland tumors of the skin. Am J Dermatopathol. 1988;10:28-35.
8. Tsubura A, Senzaki H, Sasaki M, et al. Immunohistochemical demonstration of breast-derived and/or carcinoma-associated glycoproteins in normal skin appendages and their tumors. J Cutan Pathol. 1992;19:73-79.
9. Ansai S, Koseki S, Hozumi Y, et al. An immunohistochemical study of lysozyme, CD-15 (Leu M1), and gross cystic disease fluid protein-15 in various skin tumors. Assessment of the specificity and sensitivity of markers of apocrine differentiation. Am J Dermatopathol. 1995;17:249-255.
10. Ormsby AH, Snow JL, Su WPD, et al. Diagnostic immunohistochemistry of cutaneous metastatic breast carcinoma: a statistical analysis of the utility of gross cystic disease fluid protein-15 and estrogen receptor protein. J Am Acad Dermatol. 1995;32:711-716.
11. Demirkesen C, Hoede N, Moll R. Epithelial markers and differentiation in adnexal neoplasms of the skin: an immunohistochemical study including individual cytokeratins. J Cutan Pathol. 1995;22:518-535.
12. Cotsarelis G, Sun TT, Lavker RM. Label-retaining cells reside in the bulge area of pilosebaceous unit: implications for follicular stem cells, hair cycle, and skin carcinogenesis. Cell. 1990;61:1329-1337.
13. Lyle S, Christofidou-Solomidou M, Liu Y, et al. The C8/144B monoclonal antibody recognizes cytokeratin 15 and defines the location of human follicle stem cells. J Cell Sci. 1998;111:3179-3188.
14. Jih DM, Lyle S, Elenitsas R, et al. Cytokeratin 15 expression in trichoepitheliomas and a subset of basal cell carcinomas suggests they originate from hair follicle stem cells. J Cutan Pathol. 1999;26:113-118.
15. Bieniek R, Lazar AJF, Photopoulos C, et al. Sebaceous tumors contain a subpopulation of cells expressing the keratin 15 stem cell marker. Br J Dermatol. 2007;156:378-380.
16. Hoang MP, Dresser KA, Kapur P, et al. Microcystic adnexal carcinoma: an immunohistochemical reappraisal. Mod Pathol. 2008;21:178-185.
17. Misago N, Narisawa Y. Cytokeratin 15 expression in apocrine mixed tumors of the skin and other benign neoplasms with apocrine differentiation. J Dermatol. 2006;1:2-9.
18. Minami Y, Uede K, Furukawa F, et al. Cutaneous mixed tumors: an immunohistochemical study using two antibodies, G-81 and C8/144B. J Dermatol Sci. 2004;36:180-182.
19. Li L, Mignone J, Yang M, et al. Nestin expression in hair follicle sheath progenitor cells. Proc Natl Acad Sci. 2003;100:9958-9961.
20. Wang Y, Zhang Y, Zeng Y, et al. Patterns of nestin expression in human skin. Cell Biol Int. 2006;30:144-148.
21. Hoang MP, Keady M, Mahalingam M. Expression of stem cell markers cytokeratin 15, CD34, and nestin in primary scarring and non-scarring alopecia. Br J Dermatol. 2009;160:609-615.
22. Hashimoto K. The ultrastructure of the skin of human embryos. VII. Formation of apocrine gland. Acta Derm Venereol. 1970;50:241-251.
23. Montagna W. Embryology and anatomy of the cutaneous adnexa. J Cutan Pathol. 1984;11:350-351.
24. Weedon D. Skin Pathology, 2nd ed. London, United Kingdom: Churchill Livingston; 2002:859-916.
25. Michal M, Lamovec J, Mukensnabi P, et al. Spiradenocylindromas of the skin: tumors with morphological features of spiradenoma and cylindroma in the same lesion: report of 12 cases. Pathol Int. 1999;49:419-425.
26. Uede K, Yamamoto Y, Furukawa F. Brooke-Spiegler syndrome associated with cylindroma, trichoepithelioma, spiradenoma, and syringoma. J Dermatol. 2004;31:32-38.
27. Kazakov DV, Soukup R, Mukensnabl P, et al. Brooke-Spiegler syndrome: report of a case with combined lesions containing cylindromatous, spiradenomatous, trichoblastomatous, and sebaceous differentiation. Am J Dermatopathol. 2005;27:27-33.
28. Mammino JJ, Vidmar DA. Syringocystadenoma papilliferum: a review. Int J Dermatol. 1991;30:763-766.
29. Dahlstrand J, Zimmerman LB, McKay RD, et al. Characterization of the human nestin gene reveals a close evolutionary relationship to neurofila-ments. J Cell Sci. 1992;103:589-597.
30. Amoh Y, Li L, Campillo R, et al. Implanted hair follicle stem cells form Schwann cells that support repair of severed peripheral nerves. Proc Natl Acad Sci. 2005;102:17734-17738.
31. Amoh Y, Li L, Katsuoka K, et al. Multipotent nestin-positive, keratin-negative hair-follicle bulge stem cells can form neurons. Proc Natl Acad Sci. 2005;102:5530-5534.
32. Mignone JL, Roig-Lopez JL, Fedtsova N, et al. Neural potential of a stem cell population in the hair follicle. Cell Cycle. 2007;6:2161-2170.
33. Eckert F, Betke M, Schmoeckel C, et al. Myoepithelial differentiation in benign sweat gland tumors. Demonstrated by a monoclonal antibody to alpha-smooth muscle actin. J Cutan Pathol. 1992;19:294-301.
34. Kazakov DV, Belousova IE, Bisceglia M, et al. Apocrine mixed tumor of the skin ("mixed tumor of the folliculosebaceous-apocrine complex"). Spectrum of differentiations and metaplastic changes in the epithelial, myoepithelial, and stromal components based on a histopathologic study of 244 cases. J Am Acad Dermatol. 2007;57:467-483.
35. McKee P. Pathology of the skin. 3rd ed. Philadelphia, PA: Elsevier Mosby, 2005:1594.
36. Hassan MO, Khan MA, Druse TV. Apocrine hidrocystoma: an ultrastructural study. Arch Dermatol. 1979;115:194-200.
37. Meybehm M, Fischer HP. Spiradenoma and dermal cylindroma: comparative immunohistochemical analysis and histogenetic considerations. Am J Dermatopathol. 1997;19:154-161.
38. Wiley EL, Milchgrub S, Freeman RG, et al. Sweat gland adenomas: immunohistochemical study with emphasis on myoepithelial differentiation. J Cutan Pathol. 1993;20:337-343.
39. Biemat W, Kordek R, Wozniak L. Diagnostic significance of the myoepithelial cells in the benign and malignant sweat gland tumors. Pol J Pathol. 1996;47:7-11.
40. Tellechea O, Reis JP, Ilheu O, et al. Dermal cylindroma. An immunohisto-chemical study of thirteen cases. Am J Dermatopathol. 1995;17:260-265.
41. Li H, Cherukuri P, Li N, et al. Nestin is expressed in the basal/myoepithelial layer of the mammary gland and is a selective marker of basal epithelial breast tumors. Cancer Res. 2007;67:501-510.
42. Wiese C, Rolletschek A, Kania G, et al. Nestin expression: a property of multi-lineage progenitor cells? Cell Mol Life Sci. 2004;61:2510-2522.
43. Sahlgren CM, Mikhailov A, Hellman J, et al. Mitotic reorganization of the intermediate filament protein nestin involves phosphorylation by cdc2 kinase. J Biol Chem. 2001;276:16456-16463.
44. Fidler IJ, Gersten DM, Hart IR. The biology of cancer invasion and metastasis. Adv Cancer Res. 1978;28:149-250.